ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 166 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $501,000 | +54.6% | 169,369 | -17.0% | 0.05% | +37.8% |
| Q4 2018 | $324,000 | -66.0% | 203,969 | -21.3% | 0.04% | -30.2% |
| Q3 2018 | $954,000 | +38.5% | 259,169 | +6.5% | 0.05% | +55.9% |
| Q2 2018 | $689,000 | +79.9% | 243,369 | +82.9% | 0.03% | +47.8% |
| Q4 2017 | $383,000 | -73.1% | 133,058 | -58.0% | 0.02% | -76.3% |
| Q3 2017 | $1,423,000 | -20.0% | 316,900 | -18.2% | 0.10% | -16.4% |
| Q2 2017 | $1,778,000 | +52.1% | 387,258 | +39.5% | 0.12% | +84.1% |
| Q1 2017 | $1,169,000 | +34.1% | 277,700 | +31.6% | 0.06% | +21.2% |
| Q4 2016 | $872,000 | +160.3% | 211,027 | +410.4% | 0.05% | +188.9% |
| Q3 2016 | $335,000 | +280.7% | 41,348 | +266.0% | 0.02% | +260.0% |
| Q2 2016 | $88,000 | -30.7% | 11,298 | -12.6% | 0.01% | 0.0% |
| Q1 2015 | $127,000 | – | 12,927 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
| RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
| ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
| DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
| Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
| 683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
| Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
| South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
| Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |